Important Drug Safety Update from the MHRA on Valproate and pregnancy

24th April 2018

The MHRA have issued new guidance stating that Valproate medicines (Epilim▼, Depakote▼) are contraindicated in women and girls of childbearing potential unless a Pregnancy Prevention Programme is in place.

Read the full update here: https://www.gov.uk/drug-safety-update/valproate-medicines-epilim-depakote-contraindicated-in-women-and-girls-of-childbearing-potential-unless-conditions-of-pregnancy-prevention-programme-are-met

More News

Prescriber Ready portfolio launched

The newest portfolio to join the SCRIPT eLearning programme is now available. The Prescriber Ready portfolio aims to support non-medical healthcare professionals preparing to achieve prescriber readiness. Commissioned by NHS England, learners can access the first five...